Product
Levodopa + Carbidopa
Aliases
Levodopa and carbidopa, Levodopa and carbidopa or saline
Name
Inbrija
INN Name
levodopa
FDA Approved
Yes
3 clinical trials
1 organization
1 indication
1 document
Indication
Parkinson's DiseaseClinical trial
A Phase 2a Multicentre Randomized Double Blind Placebo Controlled Study Followed by an Open Label Period, to Evaluate the Safety, Tolerability and Levodopa Pharmacokinetics in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations, Administered With Repeated Continuous Subcutaneous ND0612Status: Completed, Estimated PCD: 2015-04-26
Clinical trial
A Phase I/IIa, Single Dose, Single-centre, Randomized, Crossover, Double-blind, Placebo-controlled Study Evaluating Safety, Tolerability and Levodopa Plasma Concentration Following Administration of Subcutaneous Continuously-delivered Levodopa/Carbidopa Solution (ND0612) in PD PatientsStatus: Completed, Estimated PCD: 2013-02-26
Clinical trial
A Randomized, Double-Blind, Double-Dummy, Active-Controlled Study Comparing the Efficacy, Safety and Tolerability of ABBV-951 to Oral Carbidopa/Levodopa in Advanced Parkinson's Disease PatientsStatus: Completed, Estimated PCD: 2021-09-29
Document
DailyMed Label: InbrijaOrganization
Acorda Therapeutics, Inc.